A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: Toxicity of a three- versus a four-week schedule

Authors
Parente, B Barroso, A Conde, S Guimaraes, T Seada, J
Citation
B. Parente et al., A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: Toxicity of a three- versus a four-week schedule, SEMIN ONCOL, 28(3), 2001, pp. 10-14
Citations number
18
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754 → ACNP
Volume
28
Issue
3
Year of publication
2001
Supplement
10
Pages
10 - 14
Database
ISI
SICI code
0093-7754(200106)28:3<10:APSOGA>2.0.ZU;2-2